Item 5. Market for Registrant’s Common Equity
Item 5. Market for Registrant’s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities.
Our common stock ($0.20 par value per share) trades on the NASDAQ Global Select Market under the symbol TROW. Dividends per share during the past two years were:
1st
quarter 2nd
quarter 3rd
quarter 4th
quarter
2025 $ 1.27 $ 1.27 $ 1.27 $ 1.27
2024 $ 1.24 $ 1.24 $ 1.24 $ 1.24
See Part III, Item 12. "Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters" for information relating to shares authorized for issuance under our equity compensation plans.
The following table presents repurchase activity during the fourth quarter of 2025.
Month Total number of
shares purchased Average price
paid per share Total number of
shares purchased as
part of publicly
announced program Maximum number of
shares that may yet
be purchased under
the program
October 489,730 $ 104.03 489,730 13,078,647
November 456,981 $ 101.11 456,981 12,621,666
December 419,820 $ 104.06 419,820 12,201,846
Total 1,366,531 $ 103.06 1,366,531
Shares repurchased by us in a quarter may include repurchases conducted pursuant to publicly announced board authorizations, outstanding shares surrendered to the firm to pay the exercise price in connection with swap exercises of employee stock options and shares withheld to cover the minimum tax withholding obligation associated with the vesting of restricted stock awards. Of the total number of shares purchased during the fourth quarter of 2025, all were part of a publicly announced program.
The following table details the changes in and status of the Board of Directors’ outstanding publicly announced authorization.
Authorization dates 12/31/2024 Total number of
shares purchased Maximum number of shares that may yet be purchased at 12/31/2025
March 2020 3,377,353 (3,377,353) —
December 2024 15,000,000 (2,798,154) 12,201,846
18,377,353 (6,175,507) 12,201,846
We have 823 stockholders of record and approximately 502,000 beneficial stockholder accounts held by brokers, banks, and other intermediaries holding our common stock. Common stock owned outright by our associates and directors, combined with outstanding vested stock options and unvested restricted stock awards, total nearly 5% of our outstanding stock and outstanding vested stock options at December 31, 2025.
Item 6. Reserved.
Page 30
Table of Contents
Text extracted from the filing as submitted to EDGAR. Formatting, tables and exhibits are simplified for reading; the original document is authoritative for anything you rely on.